Trial Profile
Investigator-Initiated, Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2023
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Triamcinolone
- Indications Gouty arthritis
- Focus Therapeutic Use
- 02 Oct 2023 Status changed from suspended to discontinued.
- 10 May 2021 Planned End Date changed from 1 Dec 2020 to 15 Dec 2022.
- 10 May 2021 Planned primary completion date changed from 1 Dec 2020 to 15 Jun 2022.